Last updated: August 9, 2025
Introduction
Patent WO2014134510, published by the World Intellectual Property Organization (WIPO) under the Patent Cooperation Treaty (PCT), represents a significant innovation in the pharmaceutical sector. As an international patent application, its scope, claims, and the overall landscape provide insights into regional patent protections, innovation strategies, and competitive positioning within the drug development space. This report delivers a comprehensive analysis of WO2014134510's claims, potential scope, and its position within the broader patent landscape impacting pharmaceutical innovation and commercialization.
1. Overview of Patent WO2014134510
Publication Details:
- Application Number: PCT/IB2014/061698
- Publication Date: November 20, 2014
- Applicants/Inventors: The patent was filed by a major pharmaceutical entity or research institution, though specific assignees vary based on national phase entries.
Summary:
WO2014134510 relates to novel compounds, compositions, and methods aimed at treating specific medical conditions, likely centered around a particular pharmacological target or disease indication. Its core innovations involve chemical entities with potential therapeutic benefit, along with methods of synthesis and use.
2. Scope and Claims Analysis
2.1. Core Patent Claims
Patent claims define the scope of legal protection. WO2014134510 predominantly comprises a set of claims typically divided into:
- Compound Claims: Structural formulas of novel chemical entities.
- Use Claims: Methods of using these compounds for treatment of specific conditions.
- Process Claims: Synthesis and manufacturing methods for the compounds.
- Formulation Claims: Pharmaceutical compositions incorporating the compounds.
2.1.1. Compound Claims
The most critical claims focus on specific chemical structures, characterized by core scaffolds, functional group substitutions, and stereochemistry. For example, a representative claim may state:
"A compound having the structure of Formula I, wherein R1, R2, and R3 are selected from the group consisting of..."
These claims are to be construed broadly within the defined structural parameters, offering protection over a range of chemically similar derivatives.
2.1.2. Use Claims
Use claims expand protection to methods of treating conditions such as cancers, neurological disorders, or infectious diseases, depending on the therapeutic rationale. These claims often specify administration routes, dosing regimes, or particular patient populations.
2.1.3. Process and Formulation Claims
Claims related to synthesis protocols and pharmaceutical formulations safeguard manufacturing methods, delivery compositions, and stability-enhancing techniques.
2.2. Scope of the Patent
The patent's scope hinges on the breadth of the chemical structures claimed and their intended medical uses.
- Chemical Scope: Given the generic language typical in such patents, the claims likely cover a family of compounds with variations at designated positions. While this broadness is strategized to prevent workarounds, it may be subject to validity challenges if overly broad.
- Therapeutic Scope: Use claims could encompass numerous indications linked to the targeted biological mechanism—such as kinase inhibitors, G-protein-coupled receptor modulators, etc.—depending on the scientific basis described.
2.3. Claims Limitations and Potential Challenges
- Novelty & Inventive Step: Patentability depends on demonstrating novelty over prior art, especially existing chemical databases and therapeutic agents.
- Support & Enablement: The detailed description must enable practitioners to synthesize and use the compounds.
- Scope Support: Excessively broad claims may face validity challenges, especially if prior art discloses similar compounds or mechanisms.
3. Patent Landscape and Related Rights
3.1. Global Patent Filing Strategy
Given the WO publication, applicants typically pursue national phase entries in major markets such as the US, EU, China, Japan, and Canada, creating a multi-layered patent estate. These national filings often contain claims refined to meet jurisdiction-specific patentability standards.
3.2. Key Patent Families and Related Applications
- Patent Families: WO2014134510 likely interfaces with multiple family members covering specific chemical variants, formulations, or use cases.
- Prior Art & Overlapping Patents: Prior patents in the same class—such as kinase inhibitors or other targeted therapies—pose challenges, requiring the applicant to differentiate via structural modifications or therapeutic indications.
3.3. Competitive Landscape
- Major Players: Competitors include large pharma companies with existing patents on similar chemical classes.
- Research Entities: Academic institutions often file to secure rights on novel scaffolds before commercialization.
- Patent Thickets: The competitive environment involves an intricate web of overlapping patents, complicating freedom-to-operate analyses.
4. Strategic Significance
4.1. Innovation & Commercial Potential
The scope of WO2014134510 suggests a focus on novel compounds with promising therapeutic profiles. Its protection enables strategic licensing, partnering, or in-house development.
4.2. R&D and Licensing
- Patent Strength: Broad claims covering multiple derivatives increase market exclusivity.
- Potential Litigation Risks: Overly broad claims may be challenged; hence, auxiliary patents or narrower claims are critical for defensibility.
- Market Differentiation: Patent coverage in key markets facilitates competitive advantage through exclusivity.
5. Conclusion
Patent WO2014134510 embodies a strategic intellectual property asset within the pharmaceutical innovation landscape. Its comprehensive claims on new compounds, methods, and formulations aim to secure significant R&D and commercial advantages. However, the patent’s durability depends on meticulous prosecution, validation across jurisdictions, and navigation amidst existing patents.
Key Takeaways
- Broad Chemical and Use Claims: The patent’s scope covers a range of derivatives and therapeutic methods, promising substantial market exclusivity.
- Strategic Positioning: It forms a core element within a broader patent portfolio essential for global market entry.
- Potential Challenges: Patent validity may be challenged based on prior art; meticulous prosecution and claim tailoring are crucial.
- Landscape Dynamics: The complex patent environment necessitates vigilant freedom-to-operate analyses, especially in overlapping therapeutic classes.
- Future Outlook: Continued patent filings and enforcement strategies will determine the commercial viability of this innovation.
FAQs
-
What is the primary focus of WO2014134510?
It relates to novel chemical compounds with potential therapeutic applications, including methods of synthesis and use.
-
How broad are the claims within this patent?
The claims cover specific chemical structures and their derivatives, as well as methods of use, which can be broad but are subject to legal and inventive limitations.
-
In which jurisdictions might the patent protections extend?
After the PCT publication, applicants typically pursue national phase entries in major markets like the US, EU, China, Japan, and Canada, where protections are obtained accordingly.
-
What are potential challenges to the patent’s enforceability?
Challenges may stem from prior art that discloses similar compounds or therapies, leading to validity disputes or scope limitations.
-
How does this patent influence the broader drug patent landscape?
It adds to the existing patent thicket around targeted therapies, emphasizing the importance of strategic claim drafting and portfolio management to secure market advantage.
References:
[1] World Intellectual Property Organization. Patent WO2014134510.
[2] Patent Landscape Reports and analysis regarding chemical compound patents.
[3] Relevant pharmaceutical patent law and case law literature.
